Abeona Therapeutics
ABEO
ABEO
73 hedge funds and large institutions have $50.8M invested in Abeona Therapeutics in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.38% less ownership
Funds ownership: 1.7% → 1.32% (-0.38%)
6% less funds holding
Funds holding: 78 → 73 (-5)
28% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 18
Holders
73
Holding in Top 10
1
Calls
$114K
Puts
$22K
Top Buyers
| 1 | +$4.38M | |
| 2 | +$2.9M | |
| 3 | +$1.79M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$388K |
| 5 |
JPMorgan Chase & Co
New York
|
+$341K |
Top Sellers
| 1 | -$4.3M | |
| 2 | -$3.97M | |
| 3 | -$1.79M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.1M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$944K |